Response Evaluation in Oncology Trials
In this eBook, we review the history of response evaluation in oncology trials as it has changed alongside technology and share our view of its future.
Approaching a Post-Antibiotic Era: Trends in Antibiotic Research
This eBook provides an overview of the challenges we continue to face with antibiotic and bacterial resistance.
Predictive Resupply in Clinical Research: How to Cut Costs and Ensure Adherence to Study Protocols
This whitepaper explains the shortcomings of the floor-and-ceiling drug resupply method. We outline a 5-step algorithm for your clinical trial to cut costs and adhere to protocols.
Reconsidering India as a Clinical Trial Location
India's regulatory environment has made it difficult to conduct clinical research. This whitepaper explores how policies have evolved in recent years.
Clinical Trials in Canada: A Separate but Familiar Venue
The United States is a common site for launching Phase I-III clinical trials, but Canada offers similar prospects for trial success and should not be overlooked.
Clinical Trials in Latin America: A Region of Diversity, A World of Opportunity
Latin America, which boasts easy access to a diverse patient population, is more conducive to conducting clinical trials than ever before. Find out more in these pages.
Clinical Trials in Ukraine: Untapped Potential & Proven Experience
Despite political unrest in a small section of the country, clinical trials are thriving in Europe’s second largest country. Read our whitepaper to learn more.
Conducting Clinical Trials in Turkey: A Resource Guide for Sponsors
Turkey is an up-and-coming location for savvy clinical trial managers. Read on for a comprehensive guide to the country’s dynamic research environment.
Clinical Trials in Belarus: A Primer for Sponsors
Belarus is a hidden gem for clinical trial managers. In these pages, you will learn about its high enrollment rates, favorable cost structure, and more.
Clinical Trials in Emerging Markets: Goldmines or Landmines?
Biopharmaceutical companies are turning toward emerging markets to reduce clinical trial costs and timelines. Here, we weigh the benefits and drawbacks.
Clinical Trials in Russia:The Promise and the Approach
Thanks to its large population and centralized health care system, Russia has become an excellent choice for clinical trials. Our whitepaper details why.
Passing the Baton: The Do's and Don'ts of Study Transfer
Sponsors don’t expect to transfer responsibility of a trial to a new CRO—but it can be necessary. Here, we show what a successful transfer looks like.